Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs
Authors:
Open Access
- 29 September 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Within the prostate tumor microenvironment (TME) there are complex multi-faceted and dynamic communication occurring between cancer cells and immune cells. Macrophages are key cells which infiltrate and surround tumor cells and are recognized to significantly contribute to tumor resistance and metastases. Our understanding of their function in the TME is commonly based on in vitro and in vivo models, with limited research to confirm these model observations in human prostates. Macrophage infiltration was evaluated within the TME of human prostates after 72 h culture of fresh biopsies samples in the presence of control or enzalutamide. In addition to immunohistochemistry, an optimized protocol for multi-parametric evaluation of cellular surface markers was developed using flow cytometry. Flow cytometry parameters were compared to clinicopathological features. Immunohistochemistry staining for 19 patients with paired samples suggested enzalutamide increased the expression of CD163 relative to CD68 staining. Techniques to validate these results using flow cytometry of dissociated biopsies after 72 h of culture are described. In a second cohort of patients with Gleason grade group ≥ 3 prostate cancer, global macrophage expression of CD163 was unchanged with enzalutamide treatment. However, exploratory analyses of our results using multi-parametric flow cytometry for multiple immunosuppressive macrophage markers suggest subgroup changes as well as novel associations between circulating biomarkers like the neutrophil to lymphocyte ratio (NLR) and immune cell phenotype composition in the prostate TME. Further, we observed an association between B7–H3 expressing tumor-associated macrophages and the presence of intraductal carcinoma. The use of flow cytometry to evaluate ex vivo cultured prostate biopsies fills an important gap in our ability to understand the immune cell composition of the prostate TME. Our results highlight novel associations for further investigation.Keywords
Funding Information
- Cancer Research Society (23483)
- Canadian Urological Oncology Group
- Santé (32774)
This publication has 31 references indexed in Scilit:
- Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patientsScientific Reports, 2016
- A PCA3 gene-based transcriptional amplification system targeting primary prostate cancerOncotarget, 2015
- Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinomaOncology Letters, 2015
- CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade TherapyCancer Research, 2015
- The chemotaxis of M1 and M2 macrophages is regulated by different chemokinesJournal of Leukocyte Biology, 2014
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical ProstatectomyBioMed Research International, 2014
- Ex vivo culture of human prostate tissue and drug developmentNature Reviews Urology, 2013
- Preclinical model of organotypic culture for pharmacodynamic profiling of human tumorsProceedings of the National Academy of Sciences, 2010
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- A comparison of flow cytometry and immunohistochemistry in human colorectal cancersAPMIS, 1998